Biotechnology Companies By Operating Margin

Operating Margin
Operating MarginEfficiencyMarket RiskExp Return
1NTLA Intellia Therapeutics
72.97
 0.04 
 4.17 
 0.15 
2NTII Neurobiological Technologies
0.77
 0.00 
 0.00 
 0.00 
3VYGR Voyager Therapeutics
0.6
 0.06 
 4.65 
 0.28 
4SSIC Silver Spike Investment
0.55
 0.05 
 2.56 
 0.12 
5OCUP Ocuphire Pharma
0.54
(0.06)
 2.89 
(0.17)
6DERM Journey Medical Corp
0.5
(0.03)
 6.21 
(0.19)
7HALO Halozyme Therapeutics
0.45
 0.01 
 2.41 
 0.02 
8UTHR United Therapeutics
0.42
(0.05)
 1.63 
(0.09)
9BEAM Beam TherapeuticsInc
0.42
 0.11 
 6.25 
 0.67 
10PTGX Protagonist Therapeutics
0.38
 0.23 
 4.01 
 0.92 
11VRTX Vertex Pharmaceuticals
0.38
 0.16 
 2.03 
 0.32 
12GMAB Genmab AS
0.36
(0.11)
 2.10 
(0.23)
13GILD Gilead Sciences
0.36
(0.06)
 1.83 
(0.11)
14CRSP Crispr Therapeutics AG
0.35
 0.09 
 4.06 
 0.38 
15TRDA Entrada Therapeutics
0.32
 0.01 
 4.39 
 0.04 
16ABBV AbbVie Inc
0.32
 0.38 
 0.89 
 0.34 
17REGN Regeneron Pharmaceuticals
0.29
 0.25 
 1.11 
 0.27 
18NBIX Neurocrine Biosciences
0.29
 0.13 
 1.63 
 0.20 
19INDV Indivior PLC Ordinary
0.26
 0.11 
 4.48 
 0.47 
20HLN Haleon Plc
0.24
 0.02 
 1.45 
 0.03 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations. A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.